Evicenter
MarkdownMedical informationP&T meetings
Deucrictibant (PHA121)

On-demand treatment of hereditary angioedema attacks

Also known as PHA-022121
Manufacturer
Pharvaris
Last updated
209 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

C1 esterase inhibitor concentrates

11 evidence topics · 9 sources

Recombinant human C1 inhibitor 50 U/kg versus placebo: Study 1 in the label
Intravenous C1 inhibitor as a first-line on-demand treatment: guideline recommendations